Severe Hypoglycemia Risk Factors Identified in Insulin-Treated Type 2 Diabetes
Investigators sought to identify factors associated with increased risk for severe hypoglycemia among patients with insulin-treated type 2 diabetes.
Hypoglycemia
NAFLD May Raise Risk for Severe Hypoglycemia in T2DM
Nonalcoholic fatty liver disease is associated with a higher risk for severe hypoglycemia in patients with type 2 diabetes.
Optimal Glycemic Control Lacking in Youth and Young Adults With Diabetes
Type 1 and type 2 diabetes in children, adolescents, and young adults showed poor glycemic control in earlier studies. A new study looked for signs of improvement.
Insulin Pump Therapy and Telehealth Support Improves Glycemic Control
Continuous subcutaneous insulin infusion revolutionized insulin delivery for people with type 1 diabetes. Researchers measured several devices and their effects on glycated hemoglobin levels, in addition to telehealth support, over a 3 month period.
Incidence of Treatment Deintensification After Severe Hypoglycemic Episode Examined
This retrospective study aimed to determine the incidence of treatment deintensification in a real-world setting.
Type 1 Diabetes in Adults: A Consensus Statement From the American Diabetes Association and European Association for the Study of Diabetes
Type 1 diabetes occurs at any age and can be misdiagnosed as type 2 diabetes in adults. Better testing methods and professional education are needed.
Avoid Intensification of Diabetes Medications at Discharge in Older Adults
For older adults with diabetes hospitalized for common medical conditions, discharge with intensified diabetes medications increases short-term risk for severe hypoglycemia but does not reduce severe hyperglycemia events or HbA1c levels within one year.
Glucagon-Like Peptide 1- Receptor Agonists as Adjunct in Type 1 Diabetes
People with type 1 diabetes often have trouble achieving strict glycemic control, even with new insulin analogs and glucose monitoring systems. Researchers investigated whether efficacy could be improved with adjunct therapy.
Glucagon Emergency Kit Recalled Due to Loss of Potency
The use of affected product may fail to treat patients with severe hypoglycemia due to a loss of potency.
Biologic for Type 2 Diabetes May Offer More Glycemic Control, Weight Loss Than Insulin
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...